Abiopharma

🔍 RANKIN CLAIBORNE R JR (Executive)

Company: Hamilton Beach Brands Holding Co (HBB)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 2,515 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 29,713.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1
• Sold 1,171 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 28,542.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 1,976 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 7,846.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Acquired 1,975 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 7,869.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2

Footnotes:

• F1: N/A
• F2: Reporting Person disclaims beneficial ownership of all such shares.